Literature DB >> 22282136

To resect or not resect in metastatic gastric cancer: that is the question!

Florian Lordick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22282136     DOI： 10.1007/s10120-011-0136-z

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN： 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  13 in total

Review 1.  Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection.

Authors:  Derek G Power; Nancy E Kemeny
Journal:  Crit Rev Oncol Hematol       Date:  2010-10-22       Impact factor: 6.312

2.  Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  A Okines; M Verheij; W Allum; D Cunningham; A Cervantes
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

3.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

4.  Gene expression signature-based prognostic risk score in gastric cancer.

Authors:  Jae Yong Cho; Jae Yun Lim; Jae Ho Cheong; Yun-Yong Park; Se-Lyun Yoon; Soo Mi Kim; Sang-Bae Kim; Hoguen Kim; Soon Won Hong; Young Nyun Park; Sung Hoon Noh; Eun Sung Park; In-Sun Chu; Waun Ki Hong; Jaffer A Ajani; Ju-Seog Lee
Journal:  Clin Cancer Res       Date:  2011-03-29       Impact factor: 12.531

5.  Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study.

Authors:  Tatsuo Kanda; Kazuhito Yajima; Shin-Ichi Kosugi; Takashi Ishikawa; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  Gastric Cancer       Date:  2011-10-28       Impact factor: 7.370

6.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.

Authors:  Tetsuya Ueda; Stefano Volinia; Hiroshi Okumura; Masayoshi Shimizu; Cristian Taccioli; Simona Rossi; Hansjuerg Alder; Chang-gong Liu; Naohide Oue; Wataru Yasui; Kazuhiro Yoshida; Hiroki Sasaki; Sachiyo Nomura; Yasuyuki Seto; Michio Kaminishi; George A Calin; Carlo M Croce
Journal:  Lancet Oncol       Date:  2009-12-18       Impact factor: 41.316

7.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

8.  Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.

Authors:  Ian Chau; Andy R Norman; David Cunningham; Justin S Waters; Jacqui Oates; Paul J Ross
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

9.  Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial.

Authors:  S Lorenzen; M Hentrich; C Haberl; V Heinemann; T Schuster; T Seroneit; N Roethling; C Peschel; F Lordick
Journal:  Ann Oncol       Date:  2007-07-28       Impact factor: 32.976

10.  Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Authors:  F Lordick; B Luber; S Lorenzen; S Hegewisch-Becker; G Folprecht; E Wöll; T Decker; E Endlicher; N Röthling; T Schuster; G Keller; F Fend; C Peschel
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640
View more
  5 in total

1.  Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections.

Authors:  Nobuyuki Takemura; Akio Saiura; Rintaro Koga; Junichi Arita; Ryuji Yoshioka; Yoshihiro Ono; Naoki Hiki; Takeshi Sano; Junji Yamamoto; Norihiro Kokudo; Toshiharu Yamaguchi
Journal:  Langenbecks Arch Surg       Date:  2012-05-22       Impact factor: 3.445

Review 2.  [Therapeutic approach in oligometastatic gastric and esophageal cancer].

Authors:  T Schmidt; S P Mönig
Journal:  Chirurg       Date:  2017-12       Impact factor: 0.955

3.  Repeat hepatectomy for recurrent liver metastasis from gastric carcinoma.

Authors:  Nobuyuki Takemura; Akio Saiura; Rintaro Koga; Ryuji Yoshioka; Junji Yamamoto; Norihiro Kokudo
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

4.  Survival outcomes of management in metastatic gastric adenocarcinoma patients.

Authors:  Huang-Ming Hu; Hui-Jen Tsai; Hsiu-Ying Ku; Su-Shun Lo; Yan-Shen Shan; Hung-Chi Chang; Yee Chao; Jen-Shi Chen; Shu-Chen Chen; Chun-Ju Chiang; Anna Fen-Yau Li; Hsiu-Po Wang; Tsang-En Wang; Li-Yuan Bai; Ming-Shiang Wu; Li-Tzong Chen; Tsang-Wu Liu; Yi-Hsin Yang
Journal:  Sci Rep       Date:  2021-11-30       Impact factor: 4.379

5.  Chemotherapy for Metastatic Gastric Cancer: Does Age Matter? A Single-Center, Retrospective, Real-World Study.

Authors:  Po-Wei Liao; Shao-Bin Cheng; Cheng-Wei Chou; Hsin-Chen Lin; Cheng-Hsien Lin; Tsung-Chih Chen; Chiann-Yi Hsu; Chieh-Lin Jerry Teng; Yu-Hsuan Shih
Journal:  Clin Med Insights Oncol       Date:  2022-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.